About STRATEC SE

Company Description

STRATEC SE designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and life sciences. Furthermore, the company offers complex consumables for diagnostic and medical applications. For analyzer systems and consumables, STRATEC covers the entire value chain - from development to design and production through to quality assurance.

The partners market the systems, software, and consumables, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world. STRATEC develops its products on the basis of patented technologies.

Year founded

1979

Served area

Worldwide

Headcount

1,398

Headquarters

Gewerbestraße 37, 75217 Birkenfeld – Germany

Publications

Insider Trades

Date Trading entity / Person Association Trade type Volume Average price
17.03.23 Wolfinger, Marcus Board Buy 10,125.00 € 17.03.23
15.03.23 Büchsner, Dr. Michael Board Buy 29,380.00 € 15.03.23
15.03.23 Wolfinger, Marcus Board Buy 10,077.50 € 15.03.23
14.03.23 Büchsner, Dr. Michael Board Buy 29,680.00 € 14.03.23
13.03.23 Wolfinger, Marcus Board Buy 14,652.00 € 13.03.23
10.03.23 Heni, Prof. Dr. Georg Supervisory board Buy 27,000.00 € 10.03.23
10.03.23 Wolfinger, Marcus Board Buy 13,740.00 € 10.03.23
16.11.22 Wolfinger, Marcus Board Other 282,500.00 € 16.11.22
16.11.22 Vielsack, Dr. Claus Board Other 181,180.00 € 16.11.22
16.11.22 Vielsack, Dr. Claus Board Other 141,250.00 € 16.11.22
16.11.22 Siegle, Dr. Robert Board Other 181,180.00 € 16.11.22
16.11.22 Wolfinger, Marcus Board Other 317,065.00 € 16.11.22
16.11.22 Siegle, Dr. Robert Board Other 141,250.00 € 16.11.22

Shareholder information

Shares outstanding

12,127,995

IPO

Aug. 25, 1998

Designated Sponsor(s)

Hauck Aufhäuser Lampe Privatbank AG, Pareto Securities

Stock exchange(s)

Frankfurt Stock Exchange

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.